Published in Cancer Weekly, March 21st, 2000
"Human oral cancer cells may have any of several genetic changes, but the role of the bcl-2 oncogene is relatively unexplored," stated S.A. Gibson and colleagues, State University of New York College of Medicine, New York, USA. "To find out if this gene plays a significant role and whether it could act as a target for gene therapy of oral cancer, we have examined the effects of an anti-bcl-2 ribozyme on the phenotype of oral cancer cells."
Gibson et al. published the results of their study in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.